More than 9,000 pending lawsuits are in process against manufacturers of Xarelto alleging that the drug associated with severe risk of strokes or gastrointestinal bleeds, and uncontrollable and life-threatening internal and external bleeding. The lawsuit alleges Bayer and Janssen Pharmaceuticals failed to adequately warn doctors as well as patients about the adverse effects cause by the life threatening drug Xarelto and the manufacturers were reckless in releasing the drug to market without a corresponding antidote, which can lead Xarelto to cause someone to bleed to death. Many people who were injured by Xarelto adverse effects are filing lawsuits against the manufacture pharmaceutical companies Bayer, Johnson & Johnson’s and Janssen Pharmaceuticals and blame them of withholding the information about the lack of an antidote along with the prescribing information and they claims that if the company had warned of the risks, then patients would have been prescribed the drug warfarin, a medication in which internal bleeding can be treated with dosages of Vitamin K.
Xarelto is manufactured by Bayer and is marketed by Johnson & Johnson’s subsidiary, Janssen Pharmaceuticals. This blood thinner is used to prevent vein thrombosis (DVT) and pulmonary embolism (PE) and also used to reduce extended risk. Xarelto have no antidote to stop uncontrolled bleeding which can lead a patient to severe irreversible bleeding problems, including life-threatening internal and gastrointestinal hemorrhaging and sometimes death. A major reason for the increased risk of bleeding to death on Xarelto appears to be linked to the lack of an approved reversal agent, as there is no safe and effective antidote available that doctors can use to quickly stop hemorrhaging that may develop Anticoagulation is needed due to life-threatening or uncontrolled bleeding cause by the drugs. The manufactures are recklessly selling their drug to the consumer without any strong warning and placed their desire for profits before consumer safety.
In a recent personal product liability lawsuit, a woman from Chicago filed a lawsuit on 14th Nov in Cook County Circuit Court. The lawsuit was filed against the several drug makers over the potential adverse effects cause by the blood thinner Xarelto. The woman name Shirley A. Griffin filed the complaint against Bayer AG, Bayer Healthcare Pharmaceuticals Inc., Bayer Corporation, Bayer Healthcare LLC, Janssen Pharmaceuticals Inc., McNeil-PPC Inc., McNeil consumer Healthcare Division of McNeil-PPC Inc., McNeil Consumer & Specialty Pharmaceuticals, Johnson & Johnson, and Johnson & Johnson Services Inc. She accuses drug makers of fully disclosing the risks associated with Xarelto and falsely marketing the drug. She claims that the drug makers betrayed her and other patients into believing Xarelto was safe by their willful failure to warn of severe side effects and the potential adverse event associated with the drug.
According to the complaint, the plaintiff alleges that she suffered severe physical injuries due to the Xarelto medication. The lawsuit is represented by James A. Karamanis, of the firm of Barney & Karamanis, of Chicago and filed under the case no. 2016L01117. The Fraudulent misrepresentation, product liability, infliction of emotional distress and concealing evidence by manufacturers lead several patients to severe health issues. Rather than warn the public, Bayer and Janssen Pharmaceuticals, a subsidiary of corporate giant Johnson & Johnson, actively defended its product and failed to provide adequate warnings and communications to the medical community and end line consumers of the increased risk of serious and life threatening medical complications associated with the drug.